The achievements of stimulating the immune system through vaccination have been profound. INO s synthetic vaccines are designed to treat as well as prevent illnesses, aiming to break the body s tolerance of cancerous cells and protect against diverse while changing strains of infectious diseases. INO s SynCon vaccines are designed to provide universal cross strain protection against known as well as newly emergent unmatched strains of pathogens such as influenza. These synthetic vaccines, in combination with Inovio s proprietary electroporation delivery, have been shown in humans to generate best in class immune responses with a favorable safety profile.
Quote | Inovio Pharmaceuticals Inc. (NASDAQ:INO)
Last: | $8.33 |
---|---|
Change Percent: | 0.12% |
Open: | $8.42 |
Close: | $8.33 |
High: | $8.59 |
Low: | $8.25 |
Volume: | 136,616 |
Last Trade Date Time: | 07/03/2024 03:00:00 am |
News | Inovio Pharmaceuticals Inc. (NASDAQ:INO)
INOVIO Announces Appointment of Steven Egge as Chief Commercial Officer PR Newswire Mr. Egge brings over 25 years of biopharmaceutical experience building commercial organizations and successfully launching novel therapeutic products INOVIO poised to become a commercia...
2024-07-01 08:22:25 ET More on Inovio Pharmaceuticals Inovio Pharmaceuticals, Inc. (INO) The Citizens JMP Life Sciences Conference (Transcript) Inovio Pharmaceuticals GAAP EPS of -$1.31 misses by $0.31 Inovio Pharmaceuticals Q1 2024 Earnings Preview Read th...
Message Board Posts | Inovio Pharmaceuticals Inc. (NASDAQ:INO)
Subject | By | Source | When |
---|---|---|---|
Dengue, zika and chikungunya are among what health | KPIFF-LDDFF | investorshub | 04/29/2023 3:35:53 PM |
$INO Ya, you already know the top ten | MiamiGent | investorshub | 04/29/2023 1:53:20 AM |
can you put a neoantigen antibody onto the | doc2016 | investorshub | 04/28/2023 6:20:42 PM |
Still over 52% institutional ownership | Opus X | investorshub | 04/17/2023 12:38:14 PM |
vgxi working on alzheimer vax.....they likely need some ep? | doc2016 | investorshub | 04/09/2023 7:51:58 PM |
News, Short Squeeze, Breakout and More Instantly...
Inovio Pharmaceuticals Inc. Company Name:
INO Stock Symbol:
NASDAQ Market:
Inovio Pharmaceuticals Inc. Website:
INOVIO Announces Appointment of Steven Egge as Chief Commercial Officer PR Newswire Mr. Egge brings over 25 years of biopharmaceutical experience building commercial organizations and successfully launching novel therapeutic products INOVIO poised to become a commercia...
INOVIO Added to Russell 2000® Index Effective July 1, 2024 PR Newswire PLYMOUTH MEETING, Pa. , July 1, 2024 /PRNewswire/ -- INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect p...
Company executes capital structure management initiative to reduce total debt by purchasing for cash and exchanging for long-term debt and equity, $125 million of face value, or nearly 80% of outstanding convertible notes, at 30% discount Inseego Corp. (Nasdaq: INSG) (the “Compan...